- Skip to content [Accesskey 'S']
- Skip to navigation [Accesskey 'N']
- Go to Home page [Accesskey '1']
- Go to Site Map [Accesskey '3']
- Go to Search page [Accesskey '4']
- Go to Help page [Accesskey '6']
- Go to Complaints page [Accesskey '7']
- Go to Terms & Conditions page [Accesskey '8']
- Go to Contact Us page [Accesskey '9']
- Go to Access Key Details page (Accessibility information) [Accesskey '0']
Global Health and Pharmaceuticals Index Trust.
Cashback on your 2012 ISA Annual Management Charge
Invest at least £5,000 by 31 May and you'll get 50% cashback on your 2012 annual management charge. Terms and conditions apply.
The Global Health and Pharmaceuticals Index Trust tracks companies in the FTSE World Index which engage in health, pharmaceuticals and biotechnology.
Why invest in the Global Health and Pharmaceuticals Index Trust?
- Provides you with exposure to health, pharmaceuticals and biotechnology companies in the FTSE World Index without the risks of individual stock selection.
- Invest up to £11,280 tax-efficiently in an ISA or an unlimited amount in a unit trust.
- Minimum investment: £500 as a lump sum, or £50 a month.
- No initial charges or withdrawal fee.
- You can top-up your investment at any time.
- Long-term growth potential.
Charges
| Annual Management Charge | Extra Expenses* | More Info (PDF's) |
|---|---|---|
| 1.00% | 0.15% |
*as at 31 December 2011
Fund performance
Source: Lipper. The graph above shows the annual performance of the fund over the last five years as at 31 December 2011. They take into account the annual management charge and extra expenses, and assume net income is reinvested.
| Mar 07 to Mar 08 | Mar 08 to Mar 09 | Mar 09 to Mar 10 | Mar 10 to Mar 11 | Mar 11 to Mar 12 | |
|---|---|---|---|---|---|
| *Percentage change | -8.2% | 9.5% | 25.7% | -1.5% | 12.6% |
| **Value of £10,000 | £9,178 | £10,051 | £12,638 | £12,450 | £14,022 |
*Source: Lipper. The table above shows the annual performance of the fund over five years as at 31 March 2012. They take into account the annual management charge and extra expenses, and assume net income is reinvested.
**Source: Lipper. Assumes an investment of £10,000 on 31 March 2007. The value shows cumulative growth for each year over a five year period and includes the initial investment. The figures take into account the annual management charge and extra expenses and assume net income is reinvested.
Past performance is not a guide to future performance.
Where the fund invests
| Top ten Holdings* | |
|---|---|
| Johnson & Johnson Pfizer Novartis AG Roche Holding AG GlaxoSmithKline | Merck & Co Sanofi Abbott Laboratories Astra Zeneca Bristol-Myers Squibb Co |
*as at 31 December 2011
Before you invest
- Please remember the value of your investment and any income from it may fall as well as rise and is not guaranteed.
- You may get back less than you invest.
- Although there is no fixed term you should consider ISA and unit trust investments to be medium to long term, ideally five years or more.
- The tax efficiency of ISAs is based on current rules. The current tax situation may not be maintained. The benefit of the tax treatment depends on individual circumstances.
- The fund invests overseas. Changes in exchange rates between currencies may cause the value of your investment and the level of any income to rise or fall.
- Each trust has its own individual risks. More details about the fund specific risks can be found in the 'Key Investor Information' document. More general information can be found in 'Additional Fund Information' and 'A Guide to Investing with Us'. Before you decide to invest you must read these documents.
The FTSE World Health and Pharmaceuticals Index is calculated by FTSE International Limited (“FTSE”). FTSE does not sponsor, endorse or promote this product. All copyright in the index values and constituent list belongs to FTSE. Legal & General has obtained full licence from FTSE to use such copyright in the creation of this product. “FTSE™”, “FT-SE®” and “Footsie®” are trade marks of the London Stock Exchange PLC and The Financial Times Limited and are used by FTSE International Limited (“FTSE”) under licence. “All World” is a trade mark of FTSE.
How useful did you find this page?
0% initial charge
Before you invest you must read these
To invest in a Junior ISA
Please read our Junior ISA page to find out more. To invest:
Download our Application Form
Before you invest, you must read these:
Key Investor Information documents
A Guide to Investing in a Junior ISA with Us (PDF)
Additional Fund Information for the Junior ISA (PDF)
Junior ISA Terms and Conditions (PDF)
It's a good idea to print these documents for your records.
Fund Manager - Joseph Molloy
Joseph joined Legal & General Investment Management in 2009 and is responsible for the management of a number of international equity index portfolios.
Annual Report
Interim Report
Your recently viewed items
You need javascript enabled for us to remember your Recently Viewed Items.
You might also be interested in...
In a hurry?
We can post information on ISAs and unit trusts to you.
Fund performance table
You can find out how index-trackers have performed over the last five years.
ISA top-ups
Haven’t made use of your full ISA allowance for this year? Top-up with a lump sum or increase your direct debit.
